Physician profile
Shanthi Kumar
NPI 1497710651
$628.99
in general payments reported to CMS, 2019-2025
17 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.14 · 2023: $114 · 2024: $111 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $103.26 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $96.80 | 2023-2025 | |
| Glaxosmithkline, LLC. | $72.17 | 2023-2025 | Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $60.29 | 2023-2025 | Gemtesa |
| Amgen INC. | $42.93 | 2024-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $31.41 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.81 | 2025 | |
| Daiichi Sankyo INC. | $26.09 | 2023 | Injectafer |
| Esperion Therapeutics, INC. | $23.87 | 2025 | Nexletol |
| Novo Nordisk INC | $23.14 | 2022 | |
| Exact Sciences Corporation | $20.96 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $19.71 | 2024 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $17.67 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $16.83 | 2025 | Capvaxive, Gardasil 9 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.92 | 2025 | Strensiq |
| Astrazeneca Pharmaceuticals Lp | $13.88 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanthi Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.